Tonya Quinlan

522 total citations
16 papers, 387 citations indexed

About

Tonya Quinlan is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Tonya Quinlan has authored 16 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pharmacology. Recurrent topics in Tonya Quinlan's work include Treatment of Major Depression (5 papers), Pharmaceutical studies and practices (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Tonya Quinlan is often cited by papers focused on Treatment of Major Depression (5 papers), Pharmaceutical studies and practices (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Tonya Quinlan collaborates with scholars based in United States, Germany and United Kingdom. Tonya Quinlan's co-authors include Evelyn D. Lobo, Mary Pat Knadler, Richard F. Bergstrom, William Kielbasa, Corina Loghin, Shweta Urva, John Landry, Jill Chappell, Jennifer A. Martin and Shobha Reddy and has published in prestigious journals such as Neurology, Diabetes and The British Journal of Psychiatry.

In The Last Decade

Tonya Quinlan

16 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tonya Quinlan United States 12 183 120 62 57 49 16 387
Cynthia J. Harris United States 9 129 0.7× 179 1.5× 139 2.2× 76 1.3× 44 0.9× 13 481
Chiara Di Pace Italy 10 284 1.6× 96 0.8× 22 0.4× 71 1.2× 37 0.8× 16 499
Jun Miura Japan 10 82 0.4× 69 0.6× 68 1.1× 49 0.9× 186 3.8× 24 399
Niclas Lunder Norway 7 133 0.7× 44 0.4× 62 1.0× 96 1.7× 36 0.7× 10 355
Maike Scherf‐Clavel Germany 11 89 0.5× 80 0.7× 17 0.3× 32 0.6× 33 0.7× 36 263
Junzo Watanabe Japan 15 203 1.1× 46 0.4× 65 1.0× 112 2.0× 78 1.6× 31 466
Evangelia Eirini Tsermpini Greece 12 61 0.3× 80 0.7× 43 0.7× 104 1.8× 193 3.9× 26 552
Yaowaluck Hongkaew Thailand 15 202 1.1× 80 0.7× 28 0.5× 64 1.1× 147 3.0× 27 515
Kazushi Sawamura Japan 10 128 0.7× 88 0.7× 28 0.5× 117 2.1× 83 1.7× 15 374
Tamara Božina Croatia 12 67 0.4× 30 0.3× 34 0.5× 57 1.0× 75 1.5× 34 312

Countries citing papers authored by Tonya Quinlan

Since Specialization
Citations

This map shows the geographic impact of Tonya Quinlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tonya Quinlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tonya Quinlan more than expected).

Fields of papers citing papers by Tonya Quinlan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tonya Quinlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tonya Quinlan. The network helps show where Tonya Quinlan may publish in the future.

Co-authorship network of co-authors of Tonya Quinlan

This figure shows the co-authorship network connecting the top 25 collaborators of Tonya Quinlan. A scholar is included among the top collaborators of Tonya Quinlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tonya Quinlan. Tonya Quinlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Urva, Shweta, Tonya Quinlan, John Landry, et al.. (2022). Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Clinical Pharmacokinetics. 61(7). 1057–1067. 21 indexed citations
2.
Urva, Shweta, Tonya Quinlan, John Landry, Jennifer A. Martin, & Corina Loghin. (2021). Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Clinical Pharmacokinetics. 60(8). 1049–1059. 41 indexed citations
3.
Dowlati, Afshin, R. Donald Harvey, Richard D. Carvajal, et al.. (2021). LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial. Investigational New Drugs. 39(4). 1057–1071. 35 indexed citations
4.
Urva, Shweta, et al.. (2021). Renal Impairment Has No Impact on the Clinical Pharmacokinetics of Tirzepatide. Diabetologie und Stoffwechsel. 1 indexed citations
5.
Stauffer, Virginia L., Ira Turner, William Kielbasa, et al.. (2020). Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials. The Journal of Headache and Pain. 21(1). 79–79. 12 indexed citations
6.
Urva, Shweta, Tonya Quinlan, John Landry, Jennifer C. Martin, & Corina Loghin. (2020). 971-P: Renal Impairment Has No Impact on the Clinical Pharmacokinetics of Tirzepatide. Diabetes. 69(Supplement_1). 1 indexed citations
7.
Kielbasa, William & Tonya Quinlan. (2019). Population Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine. The Journal of Clinical Pharmacology. 60(2). 229–239. 23 indexed citations
8.
9.
Lobo, Evelyn D., Tonya Quinlan, & Apurva Prakash. (2014). Pharmacokinetics of Orally Administered Duloxetine in Children and Adolescents with Major Depressive Disorder. Clinical Pharmacokinetics. 53(8). 731–740. 6 indexed citations
10.
Kielbasa, William, Tonya Quinlan, Ling Jin, et al.. (2012). Pharmacokinetics and Pharmacodynamics of Edivoxetine (LY2216684), a Norepinephrine Reuptake Inhibitor, in Pediatric Patients with Attention-Deficit/ Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 22(4). 269–276. 13 indexed citations
11.
Prakash, Apurva, Evelyn D. Lobo, Christopher J. Kratochvil, et al.. (2012). An Open-Label Safety and Pharmacokinetics Study of Duloxetine in Pediatric Patients with Major Depression. Journal of Child and Adolescent Psychopharmacology. 22(1). 48–55. 22 indexed citations
12.
Lobo, Evelyn D., et al.. (2010). Oral Olanzapine Disposition in Adolescents with Schizophrenia or Bipolar I Disorder. Pediatric Drugs. 12(3). 201–211. 21 indexed citations
13.
Lobo, Evelyn D., Tonya Quinlan, Lisa O’Brien, Mary Pat Knadler, & Michael Heathman. (2009). Population Pharmacokinetics of Orally Administered Duloxetine in Patients. Clinical Pharmacokinetics. 48(3). 189–197. 37 indexed citations
14.
Lobo, Evelyn D., Richard F. Bergstrom, Shobha Reddy, et al.. (2008). In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine. Clinical Pharmacokinetics. 47(3). 191–202. 64 indexed citations
15.
Tohen, Mauricio, Charles L. Bowden, Smulevich Ab, et al.. (2008). Olanzapine plus carbamazepinev.carbamazepine alone in treating manic episodes. The British Journal of Psychiatry. 192(2). 135–143. 52 indexed citations
16.
Lobo, Evelyn D., Corina Loghin, Mary Pat Knadler, et al.. (2008). Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women. Clinical Pharmacokinetics. 47(2). 103–109. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia J. Harris Breakdown of academic impact, for papers by Chiara Di Pace Breakdown of academic impact, for papers by Jun Miura Breakdown of academic impact, for papers by Niclas Lunder Breakdown of academic impact, for papers by Maike Scherf‐Clavel Breakdown of academic impact, for papers by Junzo Watanabe Breakdown of academic impact, for papers by Evangelia Eirini Tsermpini Breakdown of academic impact, for papers by Yaowaluck Hongkaew Breakdown of academic impact, for papers by Kazushi Sawamura Breakdown of academic impact, for papers by Tamara Božina
Rankless by CCL
2026